Successful use of eltrombopag for surgical preparation in a patient with ANKRD26-related thrombocytopenia.
a Laboratoire d'Hématologie, CHU de Bordeaux , Pessac , France.|b Centre de Référence des Pathologies Plaquettaires , France.
Mathieu
M
Fiore
b Centre de Référence des Pathologies Plaquettaires , France.|c UMR Inserm 1062, Inra 1260, Aix-Marseille Université, CHU de La Timone , Marseille , France.
Noémie
N
Saut
b Centre de Référence des Pathologies Plaquettaires , France.|c UMR Inserm 1062, Inra 1260, Aix-Marseille Université, CHU de La Timone , Marseille , France.
Marie-Christine
MC
Alessi
d Service de Médecine Interne et Maladies Infectieuses, CHU de Bordeaux , Pessac , France.
Jean-François
JF
Viallard
D000368:Aged; D001565:Benzoates / Q000627:therapeutic use*; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use*; D036341:Intercellular Signaling Peptides and Proteins; D008297:Male; D009154:Mutation; D009687:Nuclear Proteins / Q000235:genetics*; D011300:Preoperative Care; D011720:Pyrazoles / Q000627:therapeutic use*; D013921:Thrombocytopenia / Q000175:diagnosis / Q000188:drug therapy* / Q000235:genetics*; D016896:Treatment Outcome
C583630:ANKRD26 protein, human; D001565:Benzoates; D006834:Hydrazines; D036341:Intercellular Signaling Peptides and Proteins; D009687:Nuclear Proteins; D011720:Pyrazoles; C520809:eltrombopag
ANKRD26-related thrombocytopenia; bleeding risk; eltrombopag; platelet transfusion